Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation Aerosol
Posted by
www.biotecnika.org
In a regulatory filing the company said "it has received final
approval for its Abbreviated New Drug Application (ANDA) for Albuterol
Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United
States Food and Drug Administration (US FDA)."
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-gets-final-approval-from-usfda-for-albuterol-sulfate-inhalation-aerosol/articleshow/75061892.cms
Subscribe to:
Post Comments (Atom)
Post a Comment